Addiction Medicine and the Law: Navigating Common Problems in Practice

Saturday, April 25, 2026

10:45 AM - 12:00 PM PT

Location: Harbor G-I, Level 2

Presenter(s)

Michael F. Weaver, MD, DFASAM

Professor & Medical Director
University of Texas Health Science Center at Houston
The University of Texas Health Science Center at Houston
Houston, Texas

Slides
Kelly J. Clark, MD, MBA, DFAPA, DFASAM

Founder
Addiction Crisis Solutions
Louisville, Kentucky
Margaret Jarvis, MD, DFASAM

Chief, Education
Geisinger Health System
Tunkhannock, Pennsylvania

Healthcare practitioners commonly encounter many legal and regulatory issues in Addiction Medicine practice. The panel members have expertise in navigating these common issues and will go over several cases to demonstrate ways to successfully navigate legal and regulatory aspects of Addiction Medicine practice. Cases will include: confidentiality, drug testing, impaired driving, medical necessity, disability, and more. Audience participation will be solicited throughout this workshop with smartphone-facilitated polling questions.

Learning Objectives:

Learners will be able to:

Discuss legal issues in Addiction Medicine practice, including impact on professionals and patients, as well as the healthcare system.
Recognize different settings where awareness of legal requirements are essential for a practicing Addiction Medicine professional.
Implement improved medico-legal risk management processes in Addiction Medicine practice.

Disclosure(s):

Michael F. Weaver, MD, DFASAM: No financial relationships to disclose

Kelly J. Clark, MD, MBA, DFAPA, DFASAM: Boehringer Ingelheim: Consultant/Advisory Board (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing)

Margaret Jarvis, MD, DFASAM: No financial relationships to disclose